Literature DB >> 18418613

[Organ-specific diagnosis in patients with systemic sclerosis: Recommendations of the German Network for Systemic Sclerosis (DNSS)].

N Hunzelmann1, E Genth, T Krieg, M Meurer, I Melchers, P Moinzadeh, C Pfeiffer, G Riemekasten, E Schulze-Lohoff, C Sunderkoetter, U Müller-Ladner.   

Abstract

The diagnosis and therapy of systemic sclerosis (SSc) is demanding due to its nature as a multisystem disease and its chronic, severe course. To date, there are no generally accepted recommendations for diagnostic work-up either for the time of initial disease diagnosis or for the regular follow-up clinical examinations and diagnostic procedures required. However, due to recent advances, e.g. in the therapy of pulmonary arterial hypertension, regular examinations may contribute to early recognition and treatment of developing organ involvement. This manuscript describes the recommendations for initial and follow-up organ-specific clinical examinations and diagnostic work-up as compiled and carried out by the German Network for Systemic Scleroderma [Deutsche Netzwerk für systemische Sklerodermie (DNSS)].

Entities:  

Mesh:

Year:  2008        PMID: 18418613     DOI: 10.1007/s00393-008-0291-8

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  25 in total

Review 1.  Raynaud's phenomenon.

Authors:  J A Block; W Sequeira
Journal:  Lancet       Date:  2001-06-23       Impact factor: 79.321

2.  [Systemic sclerosis--a challenge in rheumatology].

Authors:  P Saar; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2006-09       Impact factor: 1.372

Review 3.  [Raynaud phenomenon in dermatology. Part 1: Pathophysiology and diagnostic approach].

Authors:  C Sunderkötter; G Riemekasten
Journal:  Hautarzt       Date:  2006-09       Impact factor: 0.751

4.  Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life.

Authors:  Gianna Camiciottoli; Ilaria Orlandi; Maurizio Bartolucci; Eleonora Meoni; Francesca Nacci; Stefano Diciotti; Chiara Barcaroli; Maria Letizia Conforti; Massimo Pistolesi; Marco Matucci-Cerinic; Mario Mascalchi
Journal:  Chest       Date:  2007-03       Impact factor: 9.410

5.  Isolated right ventricular dysfunction in systemic sclerosis: latent pulmonary hypertension?

Authors:  S Huez; F Roufosse; J-L Vachiéry; A Pavelescu; G Derumeaux; J-C Wautrecht; E Cogan; R Naeije
Journal:  Eur Respir J       Date:  2007-08-09       Impact factor: 16.671

Review 6.  [Pulmonary arterial hypertension in collagen disease: experiences of the German Network for Systemic Scleroderma].

Authors:  N Hunzelmann; G Riemekasten
Journal:  Dtsch Med Wochenschr       Date:  2006-12-08       Impact factor: 0.628

7.  Intermediate molecular weight proteinuria and albuminuria identify scleroderma patients with increased morbidity.

Authors:  B Seiberlich; N Hunzelmann; T Krieg; M Weber; E Schulze-Lohoff
Journal:  Clin Nephrol       Date:  2008-08       Impact factor: 0.975

Review 8.  Gastrointestinal motility disorders in scleroderma.

Authors:  R W Sjogren
Journal:  Arthritis Rheum       Date:  1994-09

9.  Non-invasive evaluation of long-term cardiac effects of captopril in systemic sclerosis.

Authors:  E Kazzam; K Caidahl; R Hllgren; R Gustafsson; A Waldenström
Journal:  J Intern Med       Date:  1991-09       Impact factor: 8.989

Review 10.  Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma).

Authors:  H Sallam; T A McNearney; J D Z Chen
Journal:  Aliment Pharmacol Ther       Date:  2006-03-15       Impact factor: 8.171

View more
  5 in total

Review 1.  [Systemic sclerosis. Current classification and diagnosis of organ involvement].

Authors:  O D Persa; P Moinzadeh; N Hunzelmann
Journal:  Hautarzt       Date:  2015-08       Impact factor: 0.751

2.  [Systemic scleroderma].

Authors:  N Hunzelmann
Journal:  Hautarzt       Date:  2013-04       Impact factor: 0.751

Review 3.  [The German network for systemic sclerosis (DNSS): current data on diagnostics and therapy].

Authors:  N Hunzelmann; T Krieg
Journal:  Hautarzt       Date:  2012-04       Impact factor: 0.751

Review 4.  Extrahepatic Manifestations of Primary Biliary Cholangitis.

Authors:  Sara L Chalifoux; Peter G Konyn; Gina Choi; Sammy Saab
Journal:  Gut Liver       Date:  2017-11-15       Impact factor: 4.519

5.  Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort.

Authors:  Katharina Hanke; Cornelia Dähnrich; Claudia S Brückner; Dörte Huscher; Mike Becker; Anthonina Jansen; Wolfgang Meyer; Karl Egerer; Falk Hiepe; Gerd R Burmester; Wolfgang Schlumberger; Gabriela Riemekasten
Journal:  Arthritis Res Ther       Date:  2009-02-21       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.